Skip to main content
SpringerLink
Log in

High-Grade Prostatic Intraepithelial Neoplasia

  • Chapter
  • First Online:
Precision Molecular Pathology of Prostate Cancer

Part of the book series: Molecular Pathology Library ((MPLB))

  • 1184 Accesses

Abstract

High-grade prostatic intraepithelial neoplasia is the precursor lesion for prostatic acinar adenocarcinoma. While common spatial, epidemiological, histological and immunophenotypical features exist between high-grade prostatic intraepithelial neoplasia and adnocarcinoma, they also share different cytogenetic, mutational and molecular abnormalities which we highlight in the following chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, et al. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev. 1998;7(6):531–6.

    CAS  PubMed  Google Scholar 

  2. Ayala AG, Ro JY. Prostatic intraepithelial neoplasia: recent advances. Arch Pathol Lab Med. 2007;131(8):1257–66.

    PubMed  Google Scholar 

  3. Bostwick DG, Cheng L. Precursors of prostate cancer. Histopathology. 2012;60(1):4–27.

    Article  PubMed  Google Scholar 

  4. Bostwick DG, Liu L, Brawer MK, Qian J. High-grade prostatic intraepithelial neoplasia. Rev Urol. 2004;6(4):171–9.

    PubMed  PubMed Central  Google Scholar 

  5. Merrimen JL, Evans AJ, Srigley JR. Preneoplasia in the prostate gland with emphasis on high grade prostatic intraepithelial neoplasia. Pathology. 2013;45(3):251–63.

    Article  PubMed  Google Scholar 

  6. Montironi R, Mazzucchelli R, Lopez-Beltran A, Cheng L, Scarpelli M. Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate. Nat Clin Pract Urol. 2007;4(6):321–32.

    Article  PubMed  Google Scholar 

  7. Epstein JI, Grignon DJ, Humphrey PA, McNeal JE, Sesterhenn IA, Troncoso P, et al. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol. 1995;19(8):873–86.

    Article  CAS  PubMed  Google Scholar 

  8. Keetch DW, Humphrey P, Stahl D, Smith DS, Catalona WJ. Morphometric analysis and clinical followup of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate. J Urol. 1995;154(2 Pt 1):347–51.

    Article  CAS  PubMed  Google Scholar 

  9. Epstein JI, Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol. 2006;175(3 Pt 1):820–34.

    Article  PubMed  Google Scholar 

  10. Sakr WA, Grignon DJ, Haas GP. Pathology of premalignant lesions and carcinoma of the prostate in African-American men. Semin Urol Oncol. 1998;16(4):214–20.

    CAS  PubMed  Google Scholar 

  11. Sakr WA, Grignon DJ, Haas GP, Heilbrun LK, Pontes JE, Crissman JD. Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol. 1996;30(2):138–44.

    Article  CAS  PubMed  Google Scholar 

  12. Fowler JE Jr, Bigler SA, Lynch C, Wilson SS, Farabaugh PB. Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race. Cancer. 2001;91(7):1291–6.

    Article  PubMed  Google Scholar 

  13. Tan PH, Tan HW, Tan Y, Lim CN, Cheng C, Epstein JI. Is high-grade prostatic intraepithelial neoplasia on needle biopsy different in an Asian population: a clinicopathologic study performed in Singapore. Urology. 2006;68(4):800–3.

    Article  PubMed  Google Scholar 

  14. Vukovic B, Park PC, Al-Maghrabi J, Beheshti B, Sweet J, Evans A, et al. Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma. Oncogene. 2003;22(13):1978–87.

    Article  CAS  PubMed  Google Scholar 

  15. Meeker AK, Hicks JL, Platz EA, March GE, Bennett CJ, Delannoy MJ, et al. Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. Cancer Res. 2002;62(22):6405–9.

    CAS  PubMed  Google Scholar 

  16. Joshua AM, Vukovic B, Braude I, Hussein S, Zielenska M, Srigley J, et al. Telomere attrition in isolated high-grade prostatic intraepithelial neoplasia and surrounding stroma is predictive of prostate cancer. Neoplasia. 2007;9(1):81–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Alcaraz A, Barranco MA, Corral JM, Ribal MJ, Carrio A, Mallofre C, et al. High-grade prostate intraepithelial neoplasia shares cytogenetic alterations with invasive prostate cancer. Prostate. 2001;47(1):29–35.

    Article  CAS  PubMed  Google Scholar 

  18. Bostwick DG, Shan A, Qian J, Darson M, Maihle NJ, Jenkins RB, et al. Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma. Cancer. 1998;83(9):1995–2002.

    Article  CAS  PubMed  Google Scholar 

  19. Qian J, Bostwick DG, Takahashi S, Borell TJ, Herath JF, Lieber MM, et al. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res. 1995;55(22):5408–14.

    CAS  PubMed  Google Scholar 

  20. Jenkins RB, Qian J, Lieber MM, Bostwick DG. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res. 1997;57(3):524–31.

    CAS  PubMed  Google Scholar 

  21. Ribeiro FR, Diep CB, Jeronimo C, Henrique R, Lopes C, Eknaes M, et al. Statistical dissection of genetic pathways involved in prostate carcinogenesis. Genes Chromosomes Cancer. 2006;45(2):154–63.

    Article  CAS  PubMed  Google Scholar 

  22. Henshall SM, Quinn DI, Lee CS, Head DR, Golovsky D, Brenner PC, et al. Overexpression of the cell cycle inhibitor p16INK4A in high-grade prostatic intraepithelial neoplasia predicts early relapse in prostate cancer patients. Clin Cancer Res. 2001;7(3):544–50.

    CAS  PubMed  Google Scholar 

  23. Yang G, Goltsov AA, Ren C, Kurosaka S, Edamura K, Logothetis R, et al. Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer. Mol Cancer Res. 2012;10(2):218–29.

    Article  CAS  PubMed  Google Scholar 

  24. Kang JS, Calvo BF, Maygarden SJ, Caskey LS, Mohler JL, Ornstein DK. Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res. 2002;8(1):117–23.

    CAS  PubMed  Google Scholar 

  25. Patton KT, Chen HM, Joseph L, Yang XJ. Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia. Histopathology. 2005;47(6):597–601.

    Article  CAS  PubMed  Google Scholar 

  26. Stewart J, Fleshner N, Cole H, Sweet J. Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study. J Clin Pathol. 2007;60(7):773–80.

    Article  CAS  PubMed  Google Scholar 

  27. Yee DS, Narula N, Ramzy I, Boker J, Ahlering TE, Skarecky DW, et al. Reduced annexin II protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Arch Pathol Lab Med. 2007;131(6):902–8.

    CAS  PubMed  Google Scholar 

  28. Kollermann J, Schlomm T, Bang H, Schwall GP, von Eichel-Streiber C, Simon R, et al. Expression and prognostic relevance of annexin A3 in prostate cancer. Eur Urol. 2008;54(6):1314–23.

    Article  PubMed  Google Scholar 

  29. Bostwick DG, Meiers I, Shanks JH. Glutathione S-transferase: differential expression of alpha, mu, and pi isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma. Hum Pathol. 2007;38(9):1394–401.

    Article  CAS  PubMed  Google Scholar 

  30. Woodson K, Gillespie J, Hanson J, Emmert-Buck M, Phillips JM, Linehan WM, et al. Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens. Prostate. 2004;60(1):25–31.

    Article  CAS  PubMed  Google Scholar 

  31. Montironi R, Mazzucchelli R, Stramazzotti D, Pomante R, Thompson D, Bartels PH. Expression of pi-class glutathione S-transferase: two populations of high grade prostatic intraepithelial neoplasia with different relations to carcinoma. Mol Pathol. 2000;53(3):122–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Sutherland SI, Pe Benito R, Henshall SM, Horvath LG, Kench JG. Expression of phosphorylated-mTOR during the development of prostate cancer. Prostate. 2014;74(12):1231–9.

    Article  CAS  PubMed  Google Scholar 

  33. Dai B, Kong YY, Ye DW, Ma CG, Zhou X, Yao XD. Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics. BJU Int. 2009;104(7):1009–16.

    Article  CAS  PubMed  Google Scholar 

  34. Evren S, Dermen A, Lockwood G, Fleshner N, Sweet J. Immunohistochemical examination of the mTORC1 pathway in high grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinomas (PCa): a tissue microarray study (TMA). Prostate. 2010;70(13):1429–36.

    Article  CAS  PubMed  Google Scholar 

  35. Evren S, Dermen A, Lockwood G, Fleshner N, Sweet J. mTOR-RAPTOR and 14–3-3sigma immunohistochemical expression in high grade prostatic intraepithelial neoplasia and prostatic adenocarcinomas: a tissue microarray study. J Clin Pathol. 2011;64(8):683–8.

    Article  PubMed  Google Scholar 

  36. Ko YH, Miyake H, Behnsawy HM, Cheon J, Fujisawa M. Limited significance of activated Akt-mammalian target of rapamycin signaling pathway in prostate cancer progression. Urol Int. 2014;93(2):146–51.

    Article  CAS  PubMed  Google Scholar 

  37. Leite KR, Tomiyama A, Reis ST, Sousa-Canavez JM, Sanudo A, Camara-Lopes LH, et al. MicroRNA expression profiles in the progression of prostate cancer—from high-grade prostate intraepithelial neoplasia to metastasis. Urol Oncol. 2013;31(6):796–801.

    Article  CAS  PubMed  Google Scholar 

  38. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, et al. The miR-15a-miR-16–1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med. 2008;14(11):1271–7.

    Article  CAS  PubMed  Google Scholar 

  39. La Rocca G, Badin M, Shi B, Xu SQ, Deangelis T, Sepp-Lorenzinoi L, et al. Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway. J Cell Physiol. 2009;220(2):485–91.

    Article  PubMed  Google Scholar 

  40. Ozen M, Creighton CJ, Ozdemir M, Ittmann M. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene. 2008;27(12):1788–93.

    Article  CAS  PubMed  Google Scholar 

  41. Clark JP, Cooper CS. ETS gene fusions in prostate cancer. Nat Rev Urol. 2009;6(8):429–39.

    Article  CAS  PubMed  Google Scholar 

  42. Mosquera JM, Perner S, Genega EM, Sanda M, Hofer MD, Mertz KD, et al. Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications. Clin Cancer Res. 2008;14(11):3380–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Cerveira N, Ribeiro FR, Peixoto A, Costa V, Henrique R, Jeronimo C, et al. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions. Neoplasia. 2006;8(10):826–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Perner S, Mosquera JM, Demichelis F, Hofer MD, Paris PL, Simko J, et al. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol. 2007;31(6):882–8.

    Article  PubMed  Google Scholar 

  45. Yaskiv O, Zhang X, Simmerman K, Daly T, He H, Falzarano S, et al. The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies. Am J Surg Pathol. 2011;35(7):1062–8.

    Article  PubMed  Google Scholar 

  46. Lee SL, Yu D, Wang C, Saba R, Liu S, Trpkov K, et al. ERG expression in prostate needle biopsy: potential diagnostic and prognostic implications. Appl Immunohistochem Mol Morphol. 2015;23(7):499–505.

    Article  CAS  PubMed  Google Scholar 

  47. He H, Osunkoya AO, Carver P, Falzarano S, Klein E, Magi-Galluzzi C, et al. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN. BJU Int. 2012;110(11 Pt B):E751–5.

    Article  CAS  PubMed  Google Scholar 

  48. Park K, Tomlins SA, Mudaliar KM, Chiu YL, Esgueva R, Mehra R, et al. Antibody-based detection of ERG rearrangement-positive prostate cancer. Neoplasia. 2010;12(7):590–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, Carracedo A, et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet. 2009;41(5):619–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Park K, Dalton JT, Narayanan R, Barbieri CE, Hancock ML, Bostwick DG, et al. TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia. J Clin Oncol. 2014;32(3):206–11.

    Article  PubMed  Google Scholar 

  51. Gao X, Li LY, Zhou FJ, Xie KJ, Shao CK, Su ZL, et al. ERG rearrangement for predicting subsequent cancer diagnosis in high-grade prostatic intraepithelial neoplasia and lymph node metastasis. Clin Cancer Res. 2012;18(15):4163–72.

    Article  CAS  PubMed  Google Scholar 

  52. Allen EA, Kahane H, Epstein JI. Repeat biopsy strategies for men with atypical diagnoses on initial prostate needle biopsy. Urology. 1998;52(5):803–7.

    Article  CAS  PubMed  Google Scholar 

  53. Borboroglu PG, Sur RL, Roberts JL, Amling CL. Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy. J Urol. 2001;166(3):866–70.

    Article  CAS  PubMed  Google Scholar 

  54. Cheville JC, Reznicek MJ, Bostwick DG. The focus of “atypical glands, suspicious for malignancy” in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Am J Clin Pathol. 1997;108(6):633–40.

    Article  CAS  PubMed  Google Scholar 

  55. O’Dowd GJ, Miller MC, Orozco R, Veltri RW. Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. Urology. 2000;55(4):553–9.

    Article  PubMed  Google Scholar 

  56. Park S, Shinohara K, Grossfeld GD, Carroll PR. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol. 2001;165(5):1409–14.

    Article  CAS  PubMed  Google Scholar 

  57. Schlesinger C, Bostwick DG, Iczkowski KA. High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practice. Am J Surg Pathol. 2005;29(9):1201–7.

    Article  PubMed  Google Scholar 

  58. Merrimen JL, Jones G, Srigley JR. Is high grade prostatic intraepithelial neoplasia still a risk factor for adenocarcinoma in the era of extended biopsy sampling? Pathology. 2010;42(4):325–9.

    Article  PubMed  Google Scholar 

  59. Merrimen JL, Jones G, Walker D, Leung CS, Kapusta LR, Srigley JR. Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma. J Urol. 2009;182(2):485–90. discussion 90

    Article  PubMed  Google Scholar 

  60. Srigley JR, Merrimen JL, Jones G, Jamal M. Multifocal high-grade prostatic intraepithelial neoplasia is still a significant risk factor for adenocarcinoma. Can Urol Assoc J. 2010;4(6):434.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, McGill University Health Center, Montreal, QC, Canada

    Fadi Brimo M.D., F.R.C.P.(C)

Authors
  1. Fadi Brimo M.D., F.R.C.P.(C)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fadi Brimo M.D., F.R.C.P.(C) .

Editor information

Editors and Affiliations

  1. Pathology and Laboratory Medicine, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, New York, USA

    Brian D. Robinson

  2. Pathology and Laboratory Medicine, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, New York, USA

    Juan Miguel Mosquera

  3. Institute for Academic Medicine, Houston Methodist Hospital Pathology and Genomic Medicine, Weill Medical College of Cornell University, Houston, Texas, USA

    Jae Y. Ro

  4. Institute for Academic Medicine, Houston Methodist Hospital Pathology and Genomic Medicine, Weill Medical College of Cornell University, Houston, Texas, USA

    Mukul Divatia

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Brimo, F. (2018). High-Grade Prostatic Intraepithelial Neoplasia. In: Robinson, B., Mosquera, J., Ro, J., Divatia, M. (eds) Precision Molecular Pathology of Prostate Cancer. Molecular Pathology Library. Springer, Cham. https://doi.org/10.1007/978-3-319-64096-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64096-9_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64094-5

  • Online ISBN: 978-3-319-64096-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation